Anti-reflux infant formula market seen reaching $117.14 billion by 2030

The anti-reflux infant formula market is expanding as infant digestive health, specialty nutrition demand and pediatrician support rise worldwide. The Business Research Company projects the market will climb from $74.24 billion in 2025 to $117.14 billion by 2030, with North America leading and Asia-Pacific growing fastest.

Why it matters: - Anti-reflux infant formula is designed to reduce spit-up and regurgitation in infants with gastroesophageal reflux. - Growth in the category reflects broader demand for specialty infant nutrition, especially as parents, caregivers and clinicians look for products that support feeding comfort and nutrient retention. - The market’s projected rise signals more room for premium pediatric nutrition products and clinically targeted formulas.

What happened: - The Business Research Company published its Anti-Reflux Infant Formula Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report projects the market will grow from $74.24 billion in 2025 to $81.58 billion in 2026. - The report forecasts the market will reach $117.14 billion by 2030. - The report estimates a 9.9% CAGR in 2026 and a 9.5% CAGR through 2030. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to post the fastest growth in the coming years. - Download a free sample of the report.

The details: - Anti-reflux infant formula thickens milk to help infants retain feeds more easily. - The formula is typically recommended for babies diagnosed with gastroesophageal reflux and should be used under healthcare guidance. - Rising infant populations are supporting demand for the product. - England and Wales recorded 594,677 live births in 2024, up 0.6% from the prior year, according to the UK’s Office for National Statistics Census. - Higher workforce participation among mothers is also boosting demand for more convenient feeding options. - The US Bureau of Labor Statistics said 74% of mothers with children under 18 were employed in 2023, up 1.1 percentage points from the prior year. - Growing household incomes are making premium infant nutrition more accessible. - Statistics Iceland reported household disposable income rose 6.6% in the second quarter of 2024 versus the same period in 2023. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics, and updated graphics and tables. - View the full market report.

Between the lines: - The market’s growth is being driven by a mix of medical need and consumer purchasing power. - The fastest-growing opportunities appear to be shifting toward Asia-Pacific, while North America remains the biggest revenue base. - The report’s focus on forecasting tools and technology trends suggests suppliers are competing on product sophistication as well as reach.

What’s next: - The market is expected to keep expanding as infant reflux awareness, specialty nutrition demand and premium product adoption continue. - Clinically advanced formulas and personalized nutrition are likely to remain key growth themes through 2030. - The company says future demand will also be shaped by stronger focus on infant gut health and increased investment in specialized infant healthcare.

The bottom line: - Anti-reflux infant formula is moving from niche to bigger-scale specialty nutrition, with double-digit-style growth in the near term and a clear geographic split between market size and growth momentum.